OA
GILD icon

Oxbow Advisors’s Gilead Sciences GILD Stock Holding History

Oxbow Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-72,330
Closed -$8.1M – 214
2025
Q1 		$8.1M Buy
72,330
+389
+0.5% +$40.1K 0.86% 26
2024
Q4 		$6.65M Buy
71,941
+450
+0.6% +$40.5K 0.78% 33
2024
Q3 		$5.99M Sell
71,491
-53
-0.1% -$4.04K 0.59% 40
2024
Q2 		$4.91M Buy
+71,544
New +$4.77M 0.58% 47
2017
Q2 		– Sell
-51,395
Closed -$3.49M – 246
2017
Q1 		$3.49M Buy
51,395
+190
+0.4% +$13.4K 0.57% 56
2016
Q4 		$3.67M Sell
51,205
-2,980
-5% -$221K 0.46% 58
2016
Q3 		$4.29M Buy
+54,185
New +$4.4M 0.59% 50
2016
Q2 		– Sell
-74,325
Closed -$6.83M – 258
2016
Q1 		$6.83M Sell
74,325
-420
-0.6% -$37.9K 0.97% 26
2015
Q4 		$7.57M Buy
74,745
+18,030
+32% +$1.88M 0.95% 28
2015
Q3 		$5.56M Buy
56,715
+24,690
+77% +$2.74M 0.92% 24
2015
Q2 		$3.75M Buy
+32,025
New +$3.5M 0.48% 59

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Oxbow Advisors's GILD Position: Q2 2025 in Review

Oxbow Advisors sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 72,330 shares — an estimated $8.1M sold.

Oxbow Advisors first reported a position in GILD in Q2 2015 and held it in 11 quarters. The position peaked at $8.1M in Q1 2025. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Oxbow Advisors reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Oxbow Advisors sold 72,330 Gilead Sciences shares in Q2 2025, an estimated $8.1M.
  • Oxbow Advisors first reported a position in Gilead Sciences in Q2 2015 and held it in 11 quarters.
  • Oxbow Advisors's Gilead Sciences position peaked at $8.1M in Q1 2025.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Oxbow Advisors's 13F filing for Q2 2025, filed 29 Jul 2025.